53 related articles for article (PubMed ID: 36915463)
1. MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her-2/PI3K/AKT Signaling.
Han Y; Peng Y; Fu Y; Cai C; Guo C; Liu S; Li Y; Chen Y; Shen E; Long K; Wang X; Yu J; Shen H; Zeng S
Adv Sci (Weinh); 2020 Jul; 7(13):2000112. PubMed ID: 32670759
[TBL] [Abstract][Full Text] [Related]
2. Repression of PUM1-mediated mRNA decay activates translesion synthesis after DNA damage.
Yamada T; Sun X; Akimitsu N
Mol Cell Oncol; 2020; 7(6):1812868. PubMed ID: 33241107
[TBL] [Abstract][Full Text] [Related]
3. Inducing Cytotoxicity in Colon Cancer Cells and Suppressing Cancer Stem Cells by Dolasetron and Ketoprofen through Inhibition of RNA Binding Protein PUM1.
Gor R; Gharib A; Dharshini Balaji P; Madhavan T; Ramalingam S
Toxics; 2023 Aug; 11(8):. PubMed ID: 37624174
[TBL] [Abstract][Full Text] [Related]
4. Landscapes and mechanisms of CD8
Ding JT; Yang KP; Zhou HN; Huang YF; Li H; Zong Z
Front Immunol; 2023; 14():1149622. PubMed ID: 37180158
[TBL] [Abstract][Full Text] [Related]
5. The remodeling roles of lipid metabolism in colorectal cancer cells and immune microenvironment.
Zhong J; Guo J; Zhang X; Feng S; DI W; Wang Y; Zhu H
Oncol Res; 2022; 30(5):231-242. PubMed ID: 37305350
[TBL] [Abstract][Full Text] [Related]
6. Establishment and validation of exhausted CD8+ T cell feature as a prognostic model of HCC.
Shi J; Li G; Liu L; Yuan X; Wang Y; Gong M; Li C; Ge X; Lu S
Front Immunol; 2023; 14():1166052. PubMed ID: 37077914
[TBL] [Abstract][Full Text] [Related]
7. WTAP-induced N
Liu QZ; Zhang N; Chen JY; Zhou MJ; Zhou DH; Chen Z; Huang ZX; Xie YX; Qiao GL; Tu XH
Cancer Sci; 2024 Jun; 115(6):1749-1762. PubMed ID: 38508217
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of PUM1 by miR-218-5p promotes colorectal tumor-initiating cell properties and tumorigenesis by regulating the PI3K/AKT axis.
Liu QZ; Yu HR; Wang LP; Zhou MJ; Chen Z; Zhou DH; Chen JY; Zhang N; Huang ZX; Xie YX; Gu FF; Li K; Tu XH
J Gastrointest Oncol; 2023 Feb; 14(1):233-244. PubMed ID: 36915463
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of MUC15 by miR-183-5p.1 promotes liver tumor-initiating cells properties and tumorigenesis via regulating c-MET/PI3K/AKT/SOX2 axis.
Han T; Zheng H; Zhang J; Yang P; Li H; Cheng Z; Xiang D; Wang R
Cell Death Dis; 2022 Mar; 13(3):200. PubMed ID: 35236826
[TBL] [Abstract][Full Text] [Related]
10. MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1.
Xia LH; Yan QH; Sun QD; Gao YP
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5546-5553. PubMed ID: 30229827
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-493-5p suppresses colorectal cancer progression via the PI3K-Akt-FoxO3a signaling pathway.
Cui FC; Chen Y; Wu XY; Hu M; Qin WS
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4212-4223. PubMed ID: 32373957
[TBL] [Abstract][Full Text] [Related]
12. PUM1 Is Overexpressed in Colon Cancer Cells With Acquired Resistance to Cetuximab.
Liu Q; Xin C; Chen Y; Yang J; Chen Y; Zhang W; Ye L
Front Cell Dev Biol; 2021; 9():696558. PubMed ID: 34447749
[TBL] [Abstract][Full Text] [Related]
13. CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer.
Jiang T; Wang H; Liu L; Song H; Zhang Y; Wang J; Liu L; Xu T; Fan R; Xu Y; Wang S; Shi L; Zheng L; Wang R; Song J
Mol Cancer; 2021 Dec; 20(1):167. PubMed ID: 34922544
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
